BioPharm International-04-01-2012

Optimizing Filtration Strategies

Better news about the global economy buoys life-sciences funding.

Industry experts discuss the benefits and challenges of self-administration of injectable therapies.

A technical rountable featuring Sartorius Stedim Biotech, Pall Life Sciences, 3M Purification, Asahi Kasei Bioprocess, and Bio-Rad Laboratories.

FDA has created a dedicated cadre of foreign drug investigators and established permanent offices worldwide.

Rather than seeking a single indication for one large group, the orphan-drug approach segments the market for a drug more minutely.

Soaring opioid use creates challenges for new drug development and supply-chain control.

A closer look at elastomer changeout times provides one example of using industry knowledge to improve operations and cost.

The authors discuss the technology and guidance required to achieve good KM in a biopharmaceutical company.

Recovery audits and other best practices in procurement can improve the bottom line.

The authors describe a new assembly for bulk and final drug product filling operations.

BioPharm talks with Tarja Mottram, CEO of Action for Results, about key business considerations when starting out.

This month, we rewind to an article titled "Good Manufacturing Practices Training."

Collaboration can begin with a conversation.

The confluence of science, technology, and regulation will provide our industry with the guidance to move forward.